BHVN Earnings & Financial Statements
Biohaven Ltd.
$11.33
+$0.40(+3.66%)
27
Overall
40
Value
18
Tech
23
Quality
Market Cap
$1.65B
Volume
699.10K
52W Range
$7.48 - $18.57
Target Price
$21.27
BHVN earnings and financial statements: Biohaven Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BHVN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$745.38M | -$885.11M | -$436.05M | -$567.93M |
| EBITDA | -$727.46M | -$837.83M | -$402.64M | -$568.46M |
| Net income | -$738.82M | -$846.42M | -$408.17M | -$570.28M |
| EPS (diluted) | $-6.86 | $-9.28 | $-5.73 | $-12.75 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $451.45M | $615.11M | $513.21M | $661.78M |
| Total liabilities | $399.38M | $191.67M | $85.24M | $123.01M |
| Shareholders’ equity | $52.07M | $423.44M | $427.98M | $538.77M |
| Cash and equivalents | $229.96M | $99.13M | $248.40M | $204.88M |
| Long-term debt | $278.86M | $32.78M | $27.57M | $30.58M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$609.44M | -$582.45M | -$331.73M | -$297.69M |
| Capital expenditure | -$715.0K | -$4.05M | -$3.05M | -$41.07M |
| Free cash flow | -$610.15M | -$586.50M | -$334.77M | -$338.76M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BHVN | $11.33 | +3.7% | 699.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |